Boulder biotech raises $35 million

A Boulder biotech that's studying cancer therapies said it's raised $35 million in an initial fund-raising round. ArcherDX Inc. said the $35 million round was co-led by Boulder Ventures Ltd. and PBM Capital Group LLC. Also participating in the Series A financing round were Longwood Fund and Peierls Foundation. Kyle Lefkoff of Boulder Ventures has joined the ArcherDX board of directors. The Boulder company sa id it will use the funds to "support the rapid commercial growth of its targeted sequencing…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news